Evidence map›Paper›PMID 22521610›Full record

ArticleToxicology and applied pharmacology2012

Gender-specific reduction of hepatic Mrp2 expression by high-fat diet protects female mice from ANIT toxicity.

Bo Kong, Iván L Csanaky, Lauren M Aleksunes, Meghan Patni, Qi Chen, Xiaochao Ma, Hartmut Jaeschke, Scott Weir, Melinda Broward, Curtis D Klaassen and 1 more

Abstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. The impact of drug transporters on adverse drug reaction.European journal of drug metabolism and pharmacokinetics · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Bo KongDepartment of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Iván L Csanaky
Lauren M Aleksunes
Meghan Patni
Qi Chen
Xiaochao Ma
Hartmut Jaeschke
Scott Weir
Melinda Broward
Curtis D Klaassen
Grace L Guo
University of Kansas · USThe University of Kansas Cancer Center · USRutgers, The State University of New Jersey · USUniversity of Kansas Medical Center · US

Funding

THE ROLE OF HUMAN PXR IN ANTI-TUBERCULOSIS DRUG-INDUCED LIVER INJURYP20RR021940 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLASSEN, CURTIS D · 2006 to 2011
$12.1M
Regulation of Hepatic Uptake of Endogenous Signaling Molecules and XenobioticsR01ES009649 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CSANAKY, IVAN · 2000 to 2014
$4.0M
NEUTROPHIL-INDUCED LIVER INJURY TOXICITYR01AA012916 · NIAAA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2001 to 2012
$2.9M
Mitochondrial Dysfunction and Drug HepatotoxicityR01DK070195 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2005 to 2010
$1.8M
Tissue specific mechanism of FXR in suppressing bile-acid synthesisR01DK081343 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI GUO, GRACE L · 2008 to 2011
$1.3M
Mechanisms of Neutrophil-induced Liver ToxicityR56AA012916 · NIAAA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W · 2007 to 2007
$331k
FXR, nuclear receptors, and transcriptional regulation of liver homeostasisR56DK090036 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI GUO, GRACE L · 2011 to 2011
$328k
NCRR NIH HHS P20 RR021940NCRR NIH HHS P20-RR021940NCRR NIH HHS RR-0291940NIAAA NIH HHS AA12916NIAAA NIH HHS R01 AA012916NIAAA NIH HHS R56 AA012916NIDDK NIH HHS DK070195NIDDK NIH HHS DK081343NIDDK NIH HHS R01 DK070195NIDDK NIH HHS R01 DK081343NIDDK NIH HHS R56 DK090036NIEHS NIH HHS ES-09649NIEHS NIH HHS R01 ES009649
6 · The paper itself

Abstract

Emerging evidence suggests that feeding a high-fat diet (HFD) to rodents affects the expression of genes involved in drug transport. However, gender-specific effects of HFD on drug transport are not known. The multidrug resistance-associated protein 2 (Mrp2, Abcc2) is a transporter highly expressed in the hepatocyte canalicular membrane and is important for biliary excretion of glutathione-conjugated chemicals. The current study showed that hepatic Mrp2 expression was reduced by HFD feeding only in female, but not male, C57BL/6J mice. In order to determine whether down-regulation of Mrp2 in female mice altered chemical disposition and toxicity, the biliary excretion and hepatotoxicity of the Mrp2 substrate, α-naphthylisothiocyanate (ANIT), were assessed in male and female mice fed control diet or HFD for 4weeks. ANIT-induced biliary injury is a commonly used model of experimental cholestasis and has been shown to be dependent upon Mrp2-mediated efflux of an ANIT glutathione conjugate that selectively injures biliary epithelial cells. Interestingly, HFD feeding significantly reduced early-phase biliary ANIT excretion in female mice and largely protected against ANIT-induced liver injury. In summary, the current study showed that, at least in mice, HFD feeding can differentially regulate Mrp2 expression and function and depending upon the chemical exposure may enhance or reduce susceptibility to toxicity. Taken together, these data provide a novel interaction between diet and gender in regulating hepatobiliary excretion and susceptibility to injury.

Indexed as

Diet, High-Fat1-NaphthylisothiocyanateAnimalsATP-Binding Cassette, Sub-Family C ProteinsBileFemaleLiverMaleMiceMice, Inbred C57BLMultidrug Resistance-Associated Protein 2Sex Characteristics1-NaphthylisothiocyanateATP-Binding Cassette, Sub-Family C ProteinsMultidrug Resistance-Associated Protein 2

Identifiers

PMID22521610
PMCPMC3371772
OpenAlexW1988225800

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.